Warberg Asset Management »

Alnylam Pharmaceuticals shares owned by Warberg Asset Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Warberg Asset Management from 13F filings

Historical chart of Warberg Asset Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Warberg Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $301k 1.0k 301.14

More positions owned by Warberg Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Granite Constr Note 3.750% 5/1 (Principal)
Microchip Technology Note 1.625% 2/1 (Principal)
Astronics Corp Note 5.500% 3/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Nextnav Common Stock (NN)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Cornerstone Strategic Value (CLM)
Guardant Health Debt 1.250% 2/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)
Txnm Energy Note 5.750% 6/0 (Principal)
Liberty Media Corp Del Note 3.750% 3/1 (Principal)
Core Scientific *w Exp 01/23/202 (CORZW)
Ormat Technologies Note 2.500% 7/1 (Principal)
Apollo Global Mgmt Ser A Mand Cnv (APO.PA)

View all positions for Warberg Asset Management

Top funds holding Alnylam Pharmaceuticals

FMR
BlackRock
Capital World Investors
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Wellington Management Company
Orbis Allan Gray
Dodge & Cox

View all funds holding Alnylam Pharmaceuticals